Abivax ABVX
NASDAQ ABVX
$91.44 +1.44 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Abivax (ABVX) Net Equity Issued and Repurchased (2024 - 2026)

Updated

Abivax's Net Equity Issued and Repurchased came in at $153,432 for Q2 2026.

Analysis

Abivax (ABVX) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

For FY2024, Abivax's Net Equity Issued and Repurchased was -$17.32 million.

  • Going back by year, Net Equity Issued and Repurchased was -$36.78 million in FY2023 and -$113.83 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Abivax 7.07 Bn 4.69 Bn - 153,431.76
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 153,431.76
Mar 31, 2026 26,927.15
Dec 31, 2025 3.67 Mn
Sep 30, 2025 760.81 Mn
Dec 31, 2024 335,538.96
Sep 30, 2024 132,884.56
API Access

Abivax Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABVX&period=max&api_key=YOUR_API_KEY